Vatican and NeoStem (AMEX: NBS) host VSELs, Adult Stem Cell Meeting
VSEL™ Technology
The Vatican’s culture office and NeoStem, are hosting a 3 day conference starting Wednesday, 11/9/11 on adult stem cells, drawing scientists, patients, biotech CEOs and cardinals together. Church teaching holds that life begins at conception.
A good read/explanation: VSELs may represent the “Holy Grail” of stem cell therapy, a natural “pluripotent”. http://www.scimitarequity.com/blog/2011/05/31/neostem%e2%80%99s-amex-nbs-vsel%e2%84%a2-technology-ending-the-search-of-the-perfect-repair-cell
The conference and partnership with New York-based NeoStem is part of theVatican’s recent $1M, 5 year initiative to promote adult stem cell therapies and research, and in the process shift popular attention away from embryonic research.
- Vatican officials acknowledged the unusual nature of the partnership between the Roman Catholic Church and a publicly-traded, for-profit biotech company;
- Rev. Tomasz Trafny, head of the science department in the Vatican’s culture office, said NeoStem’s research and mission corresponded with the Vatican’s concerns to both promote research exclusively on adult stem cells, and broaden understanding about its uses to the wider public. “It’s not just an event but an itinerary of projects,” he said of the collaboration.
Supporting past blogs:
- http://www.scimitarequity.com/blog/2011/06/16/neostem-amex-nbs-partners-with-vatican%e2%80%99s-pontifical-council-to-advance-adult-stem-cell-research
- http://www.scimitarequity.com/blog/2011/08/08/neostem-amex-nbs-receipt-of-1-78m-in-dod-funding-for-its-vsel%e2%84%a2-technology-to-treat-osteoporosis
